We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.93%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$1.61B
AUM Growth
+$301M
Cap. Flow
-$470M
Cap. Flow %
-29.14%
Top 10 Hldgs %
53.1%
Holding
259
New
117
Increased
52
Reduced
16
Closed
22
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRLN
1
Merlin Inc
MRLN
$364M
$9.49M 0.59%
912,239
+786,939
+628% +$8.15M
EVAC
2
EQV Ventures Acquisition Corp II
EVAC
$599M
$8.56M 0.53%
+860,000
New +$8.55M
GTEN
3
Gores Holdings X
GTEN
$472M
$6.72M 0.42%
658,063
AACB
4
Artius II Acquisition Inc
AACB
$291M
$6.6M 0.41%
650,000
+381,998
+143% +$3.87M
ATII
5
Archimedes Tech SPAC Partners II Co
ATII
$315M
$6.26M 0.39%
611,522
+284,602
+87% +$2.91M
GPAT
6
GP-Act III Acquisition Corp
GPAT
$392M
$6.07M 0.38%
572,895
+425,152
+288% +$4.5M
PACH
7
Pioneer Acquisition I Corp
PACH
$5.9M 0.37%
+592,475
New +$5.9M
LOKV
8
DELISTED
Live Oak Acquisition Corp V
LOKV
$5.87M 0.36%
575,000
+564,938
+5,615% +$5.82M
MBVIU
9
M3-Brigade Acquisition VI Corp Units
MBVIU
$5.82M 0.36%
+575,000
New +$5.78M
HCMA
10
HCM III Acquisition Corp
HCMA
$347M
$5.81M 0.36%
+575,000
New +$5.81M
HVII
11
Hennessy Capital Investment Corp VII
HVII
$273M
$5.79M 0.36%
568,447
+5,048
+0.9% +$51.3K
DMIIU
12
Drugs Made In America Acquisition II Corp Unit
DMIIU
$5.72M 0.35%
+575,000
New +$5.73M
NPAC
13
New Providence Acquisition Corp III
NPAC
$400M
$5.68M 0.35%
+558,386
New +$5.66M
SDHI
14
Siddhi Acquisition Corp
SDHI
$364M
$5.59M 0.35%
550,000
+49,022
+10% +$496K
CCII
15
Cohen Circle Acquisition Corp II
CCII
$359M
$5.58M 0.35%
+550,000
New +$5.56M
SOUL
16
Soulpower Acquisition Corp
SOUL
$353M
$5.55M 0.34%
550,126
+110,342
+25% +$1.11M
OTGAU
17
OTG Acquisition Corp I Unit
OTGAU
$214M
$5.54M 0.34%
+550,000
New +$5.52M
HDRN
18
Hadron Energy
HDRN
$109M
$5.53M 0.34%
523,973
+508,289
+3,241% +$5.28M
AAM
19
DELISTED
AA Mission Acquisition Corp
AAM
$5.44M 0.34%
516,776
+399,701
+341% +$4.19M
DMAA
20
Drugs Made In America Acquisition Corp
DMAA
$260M
$5.42M 0.34%
528,100
+401,378
+317% +$4.12M
DRDB
21
Roman DBDR Acquisition Corp II
DRDB
$326M
$5.42M 0.34%
525,000
+345,560
+193% +$3.55M
HVMCU
22
Highview Merger Corp Units
HVMCU
$5.39M 0.33%
+532,201
New +$5.36M
SIMA
23
SIM Acquisition Corp I
SIMA
$89.9M
$5.38M 0.33%
510,032
+239,453
+88% +$2.5M
OBA
24
Oxley Bridge Acquisition Ltd
OBA
$5.35M 0.33%
+538,089
New +$5.35M
CHAC
25
DELISTED
Crane Harbor Acquisition Corp
CHAC
$5.32M 0.33%
525,000
+60,951
+13% +$612K

Similar funds

Radcliffe Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Radcliffe Capital Management held 259 positions worth $1.61B, up 23% from $1.31B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Radcliffe Capital Management withdrew a net $470M in Q3 2025, closing 22 positions and reducing 16 holdings. Its most notable exit was Oyster Enterprises II Acquisition Corp Units, an estimated $5.58M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 11% a quarter earlier, followed by Industrials and Energy.

Against the trend, Radcliffe Capital Management opened a new position in EQV Ventures Acquisition Corp II worth $8.56M.

  • Radcliffe Capital Management's largest Q3 2025 buy was EQV Ventures Acquisition Corp II: 860,000 shares worth $8.56M.
  • Radcliffe Capital Management added most to Merlin Inc in Q3 2025, an estimated $8.15M increase.
  • Radcliffe Capital Management's biggest Q3 2025 reduction was Copley Acquisition Corp, cutting an estimated $940K.
  • Radcliffe Capital Management fully exited Oyster Enterprises II Acquisition Corp Units in Q3 2025, selling an estimated $5.58M.
  • Radcliffe Capital Management's ten largest holdings make up 53% of its $1.61B portfolio in Q3 2025.
  • Radcliffe Capital Management opened 117 new positions and closed 22 in Q3 2025.
  • Radcliffe Capital Management's portfolio value rose 23% quarter-over-quarter to $1.61B.

Based on Radcliffe Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.